Suicides among the youngest U.S. teenagers were rising for years before the pandemic—with school stress, social media and guns standing as potential factors, according to a new study.Researchers found...

A new antibody drug to help fight COVID-19 infection in immune-compromised people may be available by the end of the year. AstraZeneca said Thursday that its treatment, called AZD3152, appears to work...

Young women who experience a heart attack have more adverse outcomes and are more likely to end up back in the hospital compared to men of a similar age in the year following discharge. According to a...

These days you see signs for delta-8 THC, delta-10 THC and CBD, or cannabidiol, everywhere—at gas stations, convenience stores, vape shops and online. Many people are rightly wondering which of these...

SAN DIEGO – Emerging biomarkers and treatments offer more options to diagnose and manage Alzheimer’s disease (AD) and related dementias, but high costs and potentially serious complications...

Centralized laboratory testing has been a standard tool for diagnosing common illnesses. However, laboratory-based testing generally requires expensive medical equipment and involves complex operation...

More than half of stroke survivors may develop cognitive impairment within a year after their stroke, and 1 in 3 are at risk for developing dementia within 5 years, according to a new American Heart Association...

Aila Milne was diagnosed with acute myeloid leukaemia last July when she was just five months old. She had four rounds of chemotherapy of 10 days each, with up to three blood transfusions a day to recover...

(Reuters) -Gilead Sciences Inc on Thursday reported a lower-than-expected first-quarter profit as sales from COVID-19 antiviral Veklury declined more than anticipated, and its shares fell more than 2%. Sales...

Rheumatoid arthritis explained by NHS doctor Arthritis is a condition affecting millions of people in the UK. Depending on the type of arthritis it can cause joint pain, swelling, stiffness and mobility...